AU2012283858C1 - Polypeptide separation methods - Google Patents

Polypeptide separation methods Download PDF

Info

Publication number
AU2012283858C1
AU2012283858C1 AU2012283858A AU2012283858A AU2012283858C1 AU 2012283858 C1 AU2012283858 C1 AU 2012283858C1 AU 2012283858 A AU2012283858 A AU 2012283858A AU 2012283858 A AU2012283858 A AU 2012283858A AU 2012283858 C1 AU2012283858 C1 AU 2012283858C1
Authority
AU
Australia
Prior art keywords
receptor
polypeptide
medium
glycoform
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012283858A
Other languages
English (en)
Other versions
AU2012283858B2 (en
AU2012283858A1 (en
Inventor
Austin Wayne Boesch
Glen Reed Bolton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zepteon Inc
Original Assignee
Zepteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46634526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2012283858(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zepteon Inc filed Critical Zepteon Inc
Publication of AU2012283858A1 publication Critical patent/AU2012283858A1/en
Publication of AU2012283858B2 publication Critical patent/AU2012283858B2/en
Application granted granted Critical
Publication of AU2012283858C1 publication Critical patent/AU2012283858C1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38—Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2012283858A 2011-07-20 2012-07-20 Polypeptide separation methods Ceased AU2012283858C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161509746P 2011-07-20 2011-07-20
US61/509,746 2011-07-20
PCT/US2012/047699 WO2013013193A1 (en) 2011-07-20 2012-07-20 Polypeptide separation methods

Publications (3)

Publication Number Publication Date
AU2012283858A1 AU2012283858A1 (en) 2014-03-06
AU2012283858B2 AU2012283858B2 (en) 2017-07-06
AU2012283858C1 true AU2012283858C1 (en) 2020-01-23

Family

ID=46634526

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012283858A Ceased AU2012283858C1 (en) 2011-07-20 2012-07-20 Polypeptide separation methods

Country Status (11)

Country Link
US (2) US10221210B2 (enExample)
EP (1) EP2734537B1 (enExample)
JP (1) JP2014527518A (enExample)
KR (1) KR20140062469A (enExample)
CN (1) CN103827134A (enExample)
AU (1) AU2012283858C1 (enExample)
BR (1) BR112014001120A2 (enExample)
CA (1) CA2842559A1 (enExample)
IL (1) IL230486A0 (enExample)
WO (1) WO2013013193A1 (enExample)
ZA (1) ZA201401140B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734537B1 (en) 2011-07-20 2022-12-21 Zepteon, Incorporated Polypeptide separation methods
JP6356605B2 (ja) * 2011-10-19 2018-07-11 ロシュ グリクアート アーゲー フコシル化抗体の分離法
PL2814587T3 (pl) 2012-02-15 2018-10-31 F.Hoffmann-La Roche Ag Chromatografia powinowactwa oparta na receptorze Fc
ES2834113T3 (es) 2013-03-15 2021-06-16 H Lundbeck As Purificación de anticuerpos y monitorización de la pureza
EP3048112B1 (en) * 2013-09-18 2020-03-11 Tosoh Corporation Fc-BINDING PROTEIN, METHOD FOR PRODUCING SAID PROTEIN, AND ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHODS FOR PURIFYING AND IDENTIFYING ANTIBODY USING SAID ADSORBENT
FR3025515B1 (fr) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
EP3215528B1 (en) 2014-11-06 2019-08-07 F.Hoffmann-La Roche Ag Fc-region variants with modified fcrn-binding and methods of use
US20180319838A1 (en) * 2015-11-04 2018-11-08 Biogen Ma Inc. Conjugation methods for modifying or immobilizing proteins
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US20200087390A1 (en) 2016-12-21 2020-03-19 Amgen Inc. Anti-tnf alpha antibody formulations
JP7047425B2 (ja) * 2017-02-20 2022-04-05 東ソー株式会社 抗体の分離能が向上したＦｃ結合性タンパク質およびそれを用いた抗体の分離方法
EP3702462B1 (en) 2017-10-27 2024-10-09 Tosoh Corporation Fc-BINDING PROTEIN EXHIBITING IMPROVED ALKALINE RESISTANCE, METHOD FOR PRODUCING SAID PROTEIN, ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHOD FOR SEPARATING ANTIBODY USING SAID ANTIBODY ADSORBENT
CN113272649B (zh) * 2018-10-25 2024-03-12 瑞泽恩制药公司 用于分析病毒衣壳蛋白组成的方法
JP7700092B2 (ja) * 2019-07-03 2025-06-30 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング グリコフォームの精製

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1333032A1 (en) * 2000-10-06 2003-08-06 Kyowa Hakko Kogyo Co., Ltd. Method of purifying antibody
US20030175969A1 (en) * 2000-04-12 2003-09-18 Roland Beliard Anti-rhesus d monoclonal antibodies
WO2010048313A2 (en) * 2008-10-22 2010-04-29 Biogen Idec Ma Inc. Recombinant fcrn and variants thereof for purification of fc-containing fusion proteins

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932557A (en) 1972-12-19 1976-01-13 Gulf Research & Development Company Reactive hydrophilic epoxy containing polymer
US4210723A (en) 1976-07-23 1980-07-01 The Dow Chemical Company Method of coupling a protein to an epoxylated latex
DE3543348A1 (de) 1985-12-07 1987-06-11 Bayer Ag Perlfoermige vernetzte, epoxy- und basische aminogruppen aufweisende mischpolymerisate, verfahren zu ihrer herstellung und ihre verwendung
US5260373A (en) 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
GB8902770D0 (en) 1989-02-08 1989-03-30 Bioprocessing Ltd Improvements in or relating to supports for immunoaffinity separations
SE467308B (sv) 1990-10-22 1992-06-29 Berol Nobel Ab Fast yta belagd med ett hydrofilt ytterskikt med kovalent bundna biopolymerer, saett att framstaella en saadan yta och ett konjugat daerfoer
US5456909A (en) * 1992-08-07 1995-10-10 T Cell Sciences, Inc. Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo
US5543054A (en) 1993-11-24 1996-08-06 Millipore Corporation Method and apparatus for covalent immobilization of charge- conjugated carbohydrate molecules
SE9503925D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
US5874165A (en) 1996-06-03 1999-02-23 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto polymeric subtrates
DE69840412D1 (de) * 1997-10-31 2009-02-12 Genentech Inc Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen
EP1006183A1 (en) 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
US7598055B2 (en) 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
ATE440959T1 (de) 2000-06-28 2009-09-15 Glycofi Inc Verfahren für die herstellung modifizierter glykoproteine
US7625756B2 (en) 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
KR100988949B1 (ko) 2001-10-25 2010-10-20 제넨테크, 인크. 당단백질 조성물
ITMI20020729A1 (it) 2002-04-08 2003-10-08 Resindion S R L Supporti per l'immobilizzazione covalente di enzimi
US7261893B2 (en) 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
ES2214136B1 (es) 2003-02-21 2007-05-16 Consejo Sup. De Invest. Cientificas. Nuevo metodo de inmovilizacion de enzimas y otras bio-macromoleculas sobre soportes activados con grupos epoxido conteniendo grupos ionizados en el brazo espaciador que une cada grupo epoxido a la superficie del soporte.
EP1737969B2 (en) 2004-04-15 2018-09-12 GlycoFi, Inc. Production of galactosylated glycoproteins in lower eukaryotes
JP4839583B2 (ja) 2004-07-15 2011-12-21 和光純薬工業株式会社 ＦｃγレセプターＩＩＩａに特異的な抗体およびそれを用いたＦｃγレセプターＩＩＩａの測定方法
AU2005279347A1 (en) * 2004-08-30 2006-03-09 Lonza Biologics Plc. Affinity- plus ion exchange- chromatography for purifying antibodies
ES2396555T3 (es) 2004-12-15 2013-02-22 Janssen Alzheimer Immunotherapy Anticuerpos que reconocen péptido beta amiloide
DK1869065T3 (da) 2005-03-11 2020-06-08 Wyeth Llc Fremgangsmåde til kromatografi med svag opdeling
BRPI0611600B8 (pt) * 2005-06-17 2021-05-25 Wyeth Corp método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
ES2417147T3 (es) 2005-10-21 2013-08-06 Revo Biologics, Inc. Anticuerpos con actividad de citotoxicidad celular dependiente de anticuerpos mejorada, métodos para su producción y uso
CN101365948B (zh) * 2006-01-06 2012-11-07 Emd密理博公司 亲和层析基质及其制备和使用方法
KR101495549B1 (ko) 2006-07-13 2015-02-25 와이어쓰 엘엘씨 당단백질의 생산
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
WO2008085988A1 (en) * 2007-01-05 2008-07-17 Amgen Inc. Methods of purifying proteins
US20080248510A1 (en) 2007-04-03 2008-10-09 Ulrich Brinkmann HUMAN Fc GAMMA RECEPTOR III
AU2008240078B2 (en) 2007-04-16 2012-10-25 Momenta Pharmaceuticals, Inc. Multi-dimensional chromatographic methods for separating N-glycans
US7919313B2 (en) 2007-07-12 2011-04-05 Sangamo Biosciences, Inc. Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression
US20090035807A1 (en) * 2007-07-31 2009-02-05 Wyeth Analysis of polypeptide production
CA2697091A1 (en) * 2007-08-31 2009-03-05 F. Hoffmann-La Roche Ag Glycosylation profile analysis
JP2010126436A (ja) * 2008-11-25 2010-06-10 Tosoh Corp 抗体精製用吸着剤、およびそれを用いた抗体精製方法
ES2817802T3 (es) * 2009-08-07 2021-04-08 Emd Millipore Corp Métodos para purificar una proteína objetivo de una o más impurezas en una muestra
EP2734537B1 (en) 2011-07-20 2022-12-21 Zepteon, Incorporated Polypeptide separation methods
JP6356605B2 (ja) 2011-10-19 2018-07-11 ロシュ グリクアート アーゲー フコシル化抗体の分離法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175969A1 (en) * 2000-04-12 2003-09-18 Roland Beliard Anti-rhesus d monoclonal antibodies
EP1333032A1 (en) * 2000-10-06 2003-08-06 Kyowa Hakko Kogyo Co., Ltd. Method of purifying antibody
WO2010048313A2 (en) * 2008-10-22 2010-04-29 Biogen Idec Ma Inc. Recombinant fcrn and variants thereof for purification of fc-containing fusion proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Bruhns et al., Blood 113, pages 3716-25 (2009) *
Lida et al., Clin Cancer Res, 12(9), pages 2879-87, 1 May 2006 *
Okazaki et al, J. Mol. Biol., 336, pages 1239-49 (2004) *
Shields et al, Journal of Biological Chemistry, 277, pages 26733-740 (2002) *
Tojo et al., Biol. Pharm. Bull. 32(9), pages 1604-08 (2009) *

Also Published As

Publication number Publication date
US20130084648A1 (en) 2013-04-04
US20190194248A1 (en) 2019-06-27
BR112014001120A2 (pt) 2017-02-21
WO2013013193A1 (en) 2013-01-24
KR20140062469A (ko) 2014-05-23
ZA201401140B (en) 2015-04-29
JP2014527518A (ja) 2014-10-16
US10221210B2 (en) 2019-03-05
CA2842559A1 (en) 2013-01-24
AU2012283858B2 (en) 2017-07-06
IL230486A0 (en) 2014-03-31
EP2734537A1 (en) 2014-05-28
AU2012283858A1 (en) 2014-03-06
EP2734537B1 (en) 2022-12-21
CN103827134A (zh) 2014-05-28

Similar Documents

Publication Publication Date Title
AU2012283858B2 (en) Polypeptide separation methods
DK2729482T3 (en) PROCEDURE FOR CLEANING FC-FUSION PROTEIN
EP3048899B1 (en) On-column viral inactivation methods
RU2624128C2 (ru) Аффинная хроматография с применением fc-рецепторов
US10533045B2 (en) Antibody purification and purity monitoring
KR102490956B1 (ko) 불순물을 제거하기 위한 크로마토그래피 동안의 알칼리성 세척의 용도
CN107163101B (zh) 超载和洗脱层析
KR101454316B1 (ko) 활성형 ＴＮＦＲ-Ｆｃ 융합 단백질을 제조하는 방법
CN110100007B (zh) 用于体外糖工程化抗体的酶的再使用
KR20150138273A (ko) 단백질의 피로­글루타민산 형성을 증가시키기 위한 방법
CN117887794A (zh) 用于体外糖工程化抗体的方法
CA2974033A1 (en) Anti-glycoprotein antibodies and uses thereof
RU2698671C2 (ru) КОЛИЧЕСТВЕННАЯ ОЦЕНКА НЕПРАВИЛЬНО СВЕРНУТОГО TNFR2:Fc
JP2016504337A (ja) イオン交換クロマトグラフィーを使用して高マンノースグリコフォームのレベルを制御する方法
HK40062819A (en) On-column viral inactivation methods
HK40042659A (en) Antibody purification and purity monitoring
HK40011892A (en) Re-use of enzymes in in vitro glycoengineering of antibodies
HK40011888A (en) Method for in vitro glycoengineering of antibodies
HK40011889A (en) In vitro glycoengineering of antibodies
HK40011892B (zh) 用於体外糖工程化抗体的酶的再使用

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 08 FEB 2019

CB4 Opposition filed under section 104(4)

Opponent name: PIZZEYS PATENT AND TRADE MARK ATTORNEYS PTY LTD

CC Opposition dismissed

Opponent name: PIZZEYS PATENT AND TRADE MARK ATTORNEYS PTY LTD

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT FILED 08 FEB 2019

MK14 Patent ceased section 143(a) (annual fees not paid) or expired